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Assessing CD8 T Cell Number and Dysfunction in the 
Presence of Antigen
 
By Raymond M. Welsh
 
From the Department of Pathology, University of Massachusetts Medical School, Worcester, 
Massachusetts 01655
 
CD8 T cells proliferate and differentiate into cytokine-
secreting cytolytic effectors on encounter with viral anti-
gens. As virus is cleared the activated T cells undergo apop-
tosis, but some survive and enter the memory pool where
they persist indefinitely, slowly dividing in a relatively qui-
escent state until reactivation on reexposure to the antigen
(1). The dynamics of this whole process can be variable and
change as a consequence of the antigen load, the diversity
of the available T cell repertoire, and the age of the host.
During persistent infections, T cells and antigen coexist in
an interactive environment, leading to a continued evolu-
tion of T cells that often become dysfunctional. New tech-
nologies with avidin-linked MHC tetramers, chimeric
IgG–MHC dimers, and peptide-induced intracellular cy-
tokine assays have allowed for the identification of multi-
clonal populations of antigen-specific T cells and are now
showing how T cells can be heterogeneous in their expres-
sion of surface antigens and exist in dramatically different
functional states. Under certain conditions, antigen-specific
T cells may lack effector activity, and under other condi-
tions, fully functional T cells may lack reactivity with MHC
tetramers or dimers, leading one to conclude that monitor-
ing T cell responses by a single technique may lead to mis-
conceptions of the nature of an ongoing T cell response.
 
Functional Antigen-specific T Cells.
 
In mice acutely in-
fected with a moderate dose of lymphocytic choriomenin-
gitis virus (LCMV), the frequencies of CD8 T cells detected
by MHC tetramers and MHC dimers correlate well with
the total number of activated CD8 T cells and with the fre-
 
quencies of antigen-specific cells detected by peptide-
 
induced intracellular IFN-
 
g
 
 assays (2–4); these same effector
cells are highly cytotoxic against targets pulsed with
LCMV-encoded peptides. The frequencies of T cells that
seed the memory pool are functions of the clonal burst size
of T cells during the acute response (5); this burst size is
very high in the LCMV system, and, as a consequence, 10–
15% of the spleen CD8 T cells remain specific for LCMV in
the memory pool (2, 4). In this memory state, there remains
excellent concordance among the MHC tetramer, MHC
dimer, and intracellular IFN-
 
g
 
 assays (2, 4). The memory
pool specific for each of these LCMV epitopes remains
functional and stable in the absence of immune system per-
turbance, but other infections can disrupt this memory pool
by displacing the LCMV-specific T cells with memory T
cells of other specificities (4).
 
Dysfunctional Antigen-specific T Cells.
 
The concordance
in systems analyzing T cell number and function is lost un-
der conditions of high doses of disseminating strains of
LCMV that “clonally exhaust” T cells and lead to persistent
infections (6). The nature of clonal exhaustion has not been
well understood, though it had been speculated that the
overwhelming amount of antigen may drive the T cells into
apoptosis by activation-induced cell death (AICD; reference
1). T cells from mice acutely infected with LCMV become
highly susceptible to AICD in vitro, and LCMV-specific
transgenic T cells disappear from mice infected under
clonally exhausting conditions or after injecting mice with
high doses of immunogenic peptides (6–9). However, the
use of MHC-tetramers has revealed a more complicated
process, as nucleoprotein (NP)396-specific T cells first be-
come dysfunctional and then disappear, perhaps by AICD,
whereas glycoprotein (GP)33-specific T cells become aner-
gized but remain present in the host for a long duration
(10). In this case, the GP33-specific T cells lack cytotoxic
activity or the ability to secrete cytokines. These otherwise
 
anergic cells expressed normal activation markers (CD62L
 
lo
 
,
CD44
 
hi
 
, IL-2R
 
hi
 
) and appeared to be proliferating in vivo,
as shown by uptake of bromodeoxyuridine (10). In the ab-
sence of CD4 T cells, this anergization occurred much more
rapidly, indicating that T cell exhaustion may be in part reg-
ulated by CD4 T cells (10). Why T cells of one specificity
should disappear whereas those of another specificity remain
might relate to the degree of antigen stimulation, as the NP
epitope is of higher affinity than the GP33 epitope to the
MHC and TCR (11), and substantially more NP than GP is
made in LCMV-infected cells, particularly during condi-
tions of persistent infection (12). T cell activation in regards
to cytokine production, proliferation, and cytolytic activity
all require different thresholds of peptide stimulation (13), so
it seems likely that the anergization and apoptotic processes
will also be threshold dependent, leading to the possibility of
T cells coexisting at different stages of anergy.
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Studies on the acute simian immunodeficiency virus
(SIV) infection of macaques have revealed a severe dys-
function of tetramer-staining T cells during the acute infec-
tion, under conditions where there is a substantial loss in
CD4 T cells (14). Here, CD8 T cells staining with a gag-
specific tetramer were cytolytically inactive and failed to
produce IFN-
 
g
 
 or IL-2. Some were undergoing apoptosis,
as demonstrated by staining with annexin V, whereas the
rest were alive but in a dysfunctional state. However, func-
tion could be restored after several days of incubation with
IL-2, leading the authors to speculate that, like the LCMV
system, cytokines produced by CD4 T cells may maintain
the function of the CD8 T cells (14).
The findings with LCMV and SIV would suggest that
persistent HIV infection, which is associated with a CD4 T
cell deficiency, might also be associated with dysfunctional
CD8 T cells, and this appears to be the case, though de-
scriptions of the dysfunction have differed. Gray et al.,
showed that the majority of tetramer-positive HIV-specific
T cells in asymptomatic patients lack fresh CTL activity ex
vivo, but this CTL activity could be restimulated by expo-
sure to HIV peptide in vitro (15); in this aspect they resem-
bled typical memory T cell precursors, as seen in the
LCMV system. However, Appay et al. correlated low lev-
els of cytolytic activity in HIV-specific tetramer-positive
cells with low levels of perforin (16). These cells displayed
activation markers like CD69 and were still capable of syn-
thesizing intracellular cytokines. It could be argued that an-
tigen excess had simply stimulated the T cells to discharge
their perforin, but these HIV-specific T cells remained per-
forin deficient even in patients whose antigen load was de-
pressed with antiviral therapy (16). Of note is that even
after cultivation in vitro, the HIV-specific but not the
CMV-specific T cells from the same patient remained
poorly cytolytic and low in perforin. The authors suggested
that there may be an impaired maturation of these effector
cells during the HIV infection, rather than a subsequent an-
ergization of mature T cells (16).
Both MHC dimers and MHC tetramers have been used
to examine HTLV-specific T cells from infected patients,
and the antigen-specific T cells from different patients var-
ied greatly in their ability to produce cytokines (17). There
also was considerable variation in the ability of in vitro–
cultured tetramer-positive clones to secrete cytokines and
mediate cytotoxicity (18). Hepatitis C virus–specific tet-
ramer-positive T cells isolated from viremic patients also
had deficiencies in their cytokine production and were re-
ferred to as “stunned” T cells by one group (19); function-
ality was restored to the T cells after virus was cleared in
vivo.
It therefore seems that a product of persistent infections
is T cell dysfunction that can occur in various forms, per-
haps affecting both the differentiation of T cells into effec-
tors and the dedifferentiation of effectors into less active
states. The same may be true with T cell responses to tu-
mors, which provide another form of continuous antigenic
stimulus. Only a low percentage of melanoma-specific tet-
ramer-positive T cells isolated from human peripheral
 
blood-mediated cytotoxicity or secreted cytokines in vitro,
whereas EBV-specific T cells from the same patients func-
tioned relatively normally (20), even though some hetero-
geneity in function of EBV-specific T cells has been
observed during EBV infections (21). One unique observa-
tion relevant to T cell dysfunction in the melanoma system
is that some of the antigen-specific T cells express nega-
tively signaling NK cell receptors (NKRs), such as CD94/
NKG2A; antibody to CD94 elevated the killing mediated
by tetramer-positive cells coexpressing that NKR (22).
 
Functional T Cells That Do Not React with Tetramers or
Dimers.
 
Although it is now well established that some tet-
ramer-positive T cells lack cytotoxic or cytokine-produc-
ing activities, it has also recently been shown that cytotoxic
or cytokine-producing T cells may not stain with tetra-
mers. Functional antigen-specific T cells may express this
phenotype if their TCRs are significantly downmodulated
as a consequence of antigenic exposure. In this issue, Moser
et al. document that many tetramer-negative T cells iso-
lated from mice acutely infected with polyomavirus (PyV)
are cytotoxic and secrete IFN-
 
g
 
 in response to a PyV pep-
tide (23). Using mAb specific to the TCR 
 
b 
 
chain, they
show that the TCR is downmodulated in the functional,
tetramer-negative T cells, providing some of the first clear
evidence of receptor downmodulation in a nontransgenic
T cell population in vivo.
However, there may be additional reasons for the poor
reactivity of T cells with tetramers or MHC dimers. T cells
from influenza virus–infected mice transgenic for an influ-
enza virus protein will make an effective peptide-specific
CTL and IFN-
 
g
 
 response to a peptide encoded by the
transgene, but those T cells react only weakly with MHC
tetramers (24). In that case, one would presume either that
the presence of the transgene selected for a low avidity T
cell population or else that the continued presence of the
transgene altered the ability of the influenza-specific TCR
to react with tetramers. An interesting study with influenza
virus–infected nontransgenic mice by Spencer and Braciale
showed that a Flu-specific response to a subdominant
epitope gave rise to IFN-
 
g
 
–producing CTLs that did not
stain with tetramers (25). After continued peptide stimula-
tion in vitro, these tetramer-negative Flu-specific T cells
acquired an ability to react with the tetramers. The sub-
dominant epitope had some homology to an endogenous
mouse peptide sequence, leading the authors to hypothe-
size that exposure to an endogenous peptide may have
caused a redistribution of T cell receptors such that they
did not interact appropriately with MHC tetramers. How-
ever, after a prolonged period of activation, these cells may
have realigned their receptors to make them reactive with
tetramers. An explanation for this result may come from re-
cent studies by Fahley et al., who showed, using MHC
dimers, that under conditions where changes in total TCR
expression were minimal, the activation of a cell can lead to
a 30-fold increase in the binding of MHC dimers, but not
monomers (26). Adding cholesterol to naive transgenic T
cells enhanced their ability to bind dimers, and inhibitors of
cholesterol reduced the ability of activated T cells to bind
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dimers. This may indicate that the TCR may assemble into
lipid raft-like structures that greatly affect their ability to
bind MHC dimers or tetramers.
 
T Cell Responses in Newborn Mice and in Mice with Re-
stricted TCR Repertoires.
 
The age of the host and the avail-
ability of the T cell repertoire may greatly influence the
outcome of a T cell response. For instance, inoculation of
mice with relatively low doses of LCMV within 24 h of
birth can give rise to a life-long persistent infection with
little evidence of any virus-specific CTL activity (1). Im-
munization of newborn mice can result in tolerance, and
until recently it was questioned whether newborn mice
would make T cell responses at all (27). Moser et al. show
here that PyV-infection of neonatal C3H/HeN mice,
which are genetically resistant to PyV-induced tumor for-
mation, can generate nearly as high a tetramer-specific T
cell response to PyV as adult mice; although the kinetics of
the response lag in the newborns, these T cells clear the vi-
rus and leave the host with a very high frequency of PyV-
specific memory T cells, reflective of the T cell clonal burst
size (23). Thus, newborn animals can make vigorous CTL
responses and clear virus, provided that the viral load does
not become too overwhelming, as it probably does during
LCMV infections of newborns. A different outcome with
PyV was noted in CBA/J mice, which are genetically sus-
ceptible to PyV-induced tumor formation. As a conse-
quence of thymic expression of an endogenous mammary
tumor virus superantigen, CBA/J mice have part of their T
cell repertoire deleted, including T cells needed to control
PyV infection (28, 29). These mice clear virus more slowly
and develop tumors in response to PyV. Nevertheless, even
with this more restricted T cell repertoire, a PyV tetramer-
specific T cell response was mounted in newborn CBA/J
mice but at levels about one-fourth that of the resistant
mice with the more diverse T cell repertoire (23). Of more
significance were the qualitative differences between these
responses. The viral load remained high in the sensitive
mice and their T cells were partially anergic in that they
failed to mediate CTL activity. These partially anergic
PyV-specific T cells could synthesize IFN-
 
g
 
 and, unlike
the HIV-specific T cells (16), contained normal levels of
perforin; cytotoxicity could be restored after stimulation in
culture for several days (unlike chronic HIV but like acute
SIV infections; references 14 and 16). The mechanism for
this cytolytic dysfunction is unclear but was associated with
high levels of antigen load. Thus, dysfunctional tetramer-
positive T cells are found in mice that poorly resist PyV-
induced tumor formation, just as they are found in human
melanomas (20, 22).
 
Concluding Comments.
 
New techniques for identifying
antigen-specific T cells have shown that they can be very
heterogeneous in the expression of antigenic markers,
including putative activation/memory markers like
CD45RA and CD45R0 (16, 30). Such dramatic heteroge-
neity is also seen in regards to their functionality. There ap-
pear to be several types of dysfunctional antigen-specific T
cells that can occur, particularly in the presence of high an-
tigen load: cytokine-producing, poorly cytotoxic cells low
 
in perforin (16), cytokine-producing poorly cytotoxic cells
high in perforin (23), poorly cytotoxic cells that do not
produce cytokines (10, 14), cytokine-producing cells not
readily cytotoxic (including most memory cells before acti-
vation [2, 4, 15]), cells in which this anergy can be restored
after culture in vitro with antigen and/or IL-2 (14, 15, 23),
cells in which these deficient functions can not be restored
(16), and cells that have disappeared altogether and have
presumably undergone apoptosis (6–8, 10, 14).
What is not clear is whether T cell dysfunction is a con-
sequence of functional arrest at different stages along a lin-
ear differentiation pathway or whether a cell may dys-
functionally differentiate in either of several directions.
Numerous studies have correlated T cell dysfunction with
strength of TCR stimulation and exposure to modulating
cytokines, hormones, and oxidative metabolites, so it is
possible that, depending on the relative exposure to these
signals, a T cell may become more defective in one func-
tion (such as cytotoxicity) than another (such as cytokine
production). What is clear from virtually all of these sys-
tems examined is that the anergization process is very selec-
tive to T cells specific for distinct antigens. This argues
against a generalized global immune suppression and sup-
ports the concept that at least some types of anergization
are driven through TCR-mediated signaling.
New studies have identified functional T cells that do
not react with MHC dimers or tetramers as a consequence
of low avidity due to clonal deletion of high avidity T cells
by self (or transgenically expressed) antigens (24, 25), as a
consequence of a delay in the maturation of TCR into a
more complex organization on the cell membrane, perhaps
in association with lipid rafts (24, 26), or as a consequence
of receptor downmodulation under conditions of antigen
excess (23). We are left with the conclusion that defining T
cells by only one parameter of antigenic display or biologi-
cal function is not sufficient to get an understanding of
what is really happening with T cell responses in vivo.
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